Watson Files FDA Applications for Generic Mucinex(R)
Links shared publicly online about this topic.
- 2,097total visits
Watson Files FDA Applications for Generic Mucinex(R)
View full resource at news.prnewswire.com
Tags: FDA
Most Recently Shared on April 22, 2009 at 1:45 pm By:
Watson Files FDA Applications for Generic Mucinex(R) http://twurl.nl/qstsf3
Novartis files suit against Watson over generic Exelon
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.” View full resource at news-medical.net
Most Recently Shared on November 11, 2011 at 5:17 am By:
Parkinson's Disease: Novartis files suit against Watson over generic Exelon: Watson Pharmaceuticals, Inc. today ... http://t.co/ldd6pUdi
GlaxoSmithKline files suit against Watson over generic JALYN
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market dutasteride and tamsulosin hydrochloride capsules.” View full resource at news-medical.net
Most Recently Shared on July 25, 2011 at 7:40 am By:
Medicare News: GlaxoSmithKline files suit against Watson over generic JALYN: Watson Pharmaceuticals, Inc. today ... http://bit.ly/qvxxEN
Watson seeks FDA approval to market generic version of Pfizer's Viagra
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Sildenafil Citrate Tablets, 25, 50 and 100 mg. Watson's Sildenafil Citrate tablets are a generic version of Pfizer Inc.'s Viagra®, which is indicated for the treatment of erectile dysfunction (ED).” View full resource at news-medical.net
Most Recently Shared on June 3, 2011 at 12:47 pm By:
Watson seeks FDA approval to market generic version of Pfizer's Viagra: Watson Pharmaceuticals, Inc. today confi... http://bit.ly/jEYgoE
Watson files generic Exalgo ANDA, confirms patent challenge from Mallinckrodt
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. -- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Hydromorphone Hydrochloride Extended-release Tablets, 8 mg, 12 mg, and 16 mg.” View full resource at news-medical.net
Most Recently Shared on December 15, 2010 at 12:09 pm By:
Medicare News: Watson files generic Exalgo ANDA, confirms patent challenge from Mallinckrodt: Watson Pharmaceuti... http://bit.ly/f0gFg0
Watson, Natco confirm development agreement for generic Revlimid
news-medical.net — “Watson Pharmaceuticals, Inc. and Natco Pharma Limited today confirmed an exclusive, U.S. development and license agreement, to develop and commercialize lenalidomide 5, 10, 15 and 25 mg tablets. The companies also confirmed that Natco has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lenalidomide 5, 10, 15 and 25 mg product. Natco's lenalidomide tablets are generic versions of Celgene's Revlimid ® Tablets.” View full resource at news-medical.net
Most Recently Shared on December 7, 2010 at 3:34 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Watson, Natco confirm development agreement for generic Revlimid: Watson Pharmaceuticals, Inc. an... http://bit.ly/gdcLq8
Watson Pharmaceuticals, Inc. | Investors |
ir.watson.com — “Watson Pharmaceuticals, Inc. | Investors |” View full resource at ir.watson.com
Most Recently Shared on February 22, 2010 at 2:28 pm By:
eyeonfda Pharma and Health Lawyer
Watson Files FDA Application for Generic Aplenzin(TM) ER - http://ow.ly/19SbN
Watson Files FDA Application for Generic Aplenzin(TM) ER -- MORRISTOWN, N.J., Feb. 22 /PRNewswire-FirstCall/ --
prnewswire.com — “Watson Files FDA Application for Generic Aplenzin(TM) ER. - Paragraph IV Litigation Underway -.” View full resource at prnewswire.com
Most Recently Shared on February 22, 2010 at 1:18 pm By:
Watson Files FDA Application for Generic Aplenzin(TM) ER. http://bit.ly/9iKrP5
Watson Pharmaceuticals, Inc. | Investors |
ir.watson.com — “Watson Pharmaceuticals, Inc. | Investors |” View full resource at ir.watson.com
Most Recently Shared on January 19, 2010 at 3:56 pm By:
eyeonfda Pharma and Health Lawyer
Watson Confirms Filing of FDA Application for Generic Lidoderm(R) - http://ow.ly/YcSf
Watson Pharmaceuticals, Inc. | Investors |
ir.watson.com — “Watson Pharmaceuticals, Inc. | Investors |” View full resource at ir.watson.com
Most Recently Shared on January 8, 2010 at 2:02 pm By:
eyeonfda Pharma and Health Lawyer
Watson is busy - Watson Files FDA Application for Generic LoSeasonique(R) http://ow.ly/UctP
Watson Pharmaceuticals, Inc. | Investors |
ir.watson.com — “Watson Pharmaceuticals, Inc. | Investors |” View full resource at ir.watson.com
Most Recently Shared on December 4, 2009 at 2:01 pm By:
eyeonfda Pharma and Health Lawyer
Watson Files FDA Application for Generic Rozerem(R) http://ow.ly/IxAJ
Advertisement
